It is sold in weekly subcutaneous injections at five doses from 2.5 mg through 15 mg, and the Phase 3 SURMOUNT trials showed average weight loss of roughly 20 to 22 percent at the highest dose over 72 weeks
Several trial limitations, including the small sample size, limit the interpretation of these preliminary findings, which require validation in a larger trial
1997 Mar
.An exclusive and original product by Myprotein L Carnitine L Tartrate, Microcrystalline Cellulose (Bulking Agent), Calcium Carbonate DC 90% (Bulking Agent), Magnesium Stearate (Anti-Caking Agent), Silicon Dioxide (Anti-Caking Agent), HydroxyPropylMethylCellulose (Glazing Agent), Glycerine - Vegetable (Glazing Agent), Carnauba Wax (Glazing Agent)
McGraw-Hill / Lange rxlist.com (Tragenta ) Alogliptin Trade Name: Nesina Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: does not undergo significant metabolism, and is mostly excreted unchanged in the urine (76%) and feces (13%) dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Learn more in our guide to the best peptides for weight loss research
